protein synthesis inhibitors 1.ppt

18
Dr Khulood Alsaraf Dr Khulood Alsaraf

Upload: alikhasaki

Post on 12-Nov-2014

45 views

Category:

Documents


1 download

DESCRIPTION

فارما

TRANSCRIPT

Page 1: protein synthesis inhibitors 1.ppt

Dr Khulood AlsarafDr Khulood AlsarafDr Khulood AlsarafDr Khulood Alsaraf

Page 2: protein synthesis inhibitors 1.ppt

Tetracyclines Tetracyclines are :-

Tetracycline, Demeclocycline, Doxycycline & Minocycline

-All Tetracyclines have a similar mechanism of action

-They have different chemical structures &are produced by different species of streptomyces

-Structural analogues of these comp. have been synthesized to improve pharmacokinetic properties & antimicrobial activity.

-Tetracyclines bind to 30S ribosome & there by prevent binding of aminoacyl transfer RNA [ tRNA ] to the A site [ acceptor site ] on the 50S ribosomal unit.

Page 3: protein synthesis inhibitors 1.ppt

-Tetracyclines affect both eukaryotic & prokaryotic cells but are selectively toxic for bac. because they readily penetrate microbial memb. & accumulate in the cytoplasm through an energy – dependent Tetracycline transport system that is absent from mammalian cells. -Resistance is related largely to changes in cell permeability and a resultant decreased accumulation of drug due to increased efflux from the cell by an energy-dependent mechanism.

.

Page 4: protein synthesis inhibitors 1.ppt
Page 5: protein synthesis inhibitors 1.ppt
Page 6: protein synthesis inhibitors 1.ppt

Tetracyclines have broad spectrum activity & are effective against both gm-ve & gm+ve bacteria, including Rickettsia, Coxiella, Mycoplama pneumonia, Chlamydia spp. and some spirochetes.

Significant differences in serum half – life allow the grouping of the Tetracyclines into subclasses :-1- short acting [Tetracycline]

2- Intermediate acting [ Demeclocycline ]

3- Long acting [ Minocycline & Doxycycline ]

Page 7: protein synthesis inhibitors 1.ppt

Clinical uses

The selection of an agent, therefore is based on tolerance, ease of administration and cost.The restriction of their use in pregnancy and in patients under the age of 8 years applies to all preparations.1-Doxycycline, with its longer half-life and lack of nephrotoxicity, is a popular choice for patients with pre-existing renal disease or those who are at risk of developing renal insufficiency. [ The lack of nephrotoxicity is related mainly to biliary excretion, which is the primary route of doxycycline elimination.]2-Doxycycline is a potential first-line agent in the prophylaxis of anthrax after exposure.3-Doxycycline is the drug of choice for primary stage of Lyme disease in adults and children older than 8 years.

Page 8: protein synthesis inhibitors 1.ppt

4-Minocycline is an effective alternative to rifampin for eradication of meningococci.5-The tetracyclines are still the drugs of choice for treatment of cholera, diseases caused by Rickettsia and coxilla, the chlamydial diseases (trachoma and lymphogranuloma) and non-specific urethritis.6-They are also effective in the treatment of brucellosis, and infection caused by Mycoplasma spp.7-Tetracyclines are clinically effective in the treatment of acne because of their antioxidant effect.8-In mild to moderate attacks of pelvic inflammatory disease as a result of the drug’s action on anaerobic bacteria and Chlamydia.

Page 9: protein synthesis inhibitors 1.ppt
Page 10: protein synthesis inhibitors 1.ppt

Adverse effects

1- gastric disturbances 2- fatal hepatotoxicity 3- photosensitivity 4- dizziness, nausea, vomiting occur as vestibular problems with mioncycline 5- effect on calcified tissues deposition in the bone occur during calcification in growing children, this causes discoloration & hyperplasia of the teeth. 6- superinfection over growth of candida or resistant staph. [ in the intestine] may occur.

C.I 1- in renally – impaired patients [ except doxycycline ] 2- in pregnant women 3- breast – feeding women 4- in children under 8 years of age

Page 11: protein synthesis inhibitors 1.ppt

GlycylcyclinesTigecycline Have very broad antibacterial spectrumEffective against S.aureus including methecillin-resistance, vancomycin-resistance strains, streptococci, pencillin-susceptible and resistance strains, entericocci, gm+ve rods, anaerobes both gm+ve and gm-ve, chlamydia sp., proteus sp., and p aeruginosa.Given by IV injection only, rapidly distributed into body tissues, metabolized by liver and eliminated primarily via biliary/fecal excretion.It is FDA-approved for treatment of skin infection, intra- abdominal infections, and community-acquired pneumonia.Main adverse effects include:1- nausea, vomiting and diarrhea2- hypersensitivity reactions (drug fever, skin rash)3- readily bound to calcium deposited in newly formed bone or teeth in young children causing discoloration and enamel dysplasia.4- impaired hepatic function5- renal tubular acidosis and other renal injury.

Page 12: protein synthesis inhibitors 1.ppt

Macrolides/ Ketolides-They consist of a large lactone ring to which sugar are attached.

-Macrolides include :-Erythromycin, Clarithromycin, Azithromycin, & Telithromycin.

-Macrolides bind to the 50S ribosomal subunit of bacteria but not to the 80S mammalian ribosome, this accounts for its selective toxicity

-Binding to the ribosome occurs at a site near peptidyl transferase, with a resultant inhibition of translocation, peptide bond formation & release of oligopeptidyl tRNA .

-They are effective against a no. of organisms, including Mycoplama spp., H. influenzae, Strep., Staph. & Gonococci.

Page 13: protein synthesis inhibitors 1.ppt

-Clarithromycin is very effective against H. influenzae, & Mycobacterium avium – intracellulare.

-Azithromycin is superior against Neisseria, H. influenzae but less active against mycobacterial species.

- Clarithromycin & Azithromycin are among the drug of choice in treating disseminated Mycobacterium avium complex.T1/2 of Erythromycin 1-4 hrs

T1/2 of Clarithromycin 3-7 hrs

T1/2 of Azithromycin approaches 68 hrs

Page 14: protein synthesis inhibitors 1.ppt

Clinical uses1-Treatment of mycoplasma pneumonia infections2-Eradication of corynebacterium diphtheriae ( from pharyngeal carrier)3-Chlamydial infections4-For campylobacter enteritis and chlamydial conjunctivitis and prevention of secondary pneumonia in neonates.5-Staphylococcus are generally susceptible to erythromycin, so it is suitable alternative drug for the penicillin-hypersensitive individual.6-It is a second-line drug for the treatment of gonorrhea and syphilis.7-Clarithromycin→ has activity against toxoplasma gondi and mycobacterium avium-intracellulare.8-The prolonged half-life and protein binding and the use of a single one-time dose of azithromycin appear to be extremely beneficial in the treatment of sexually transmitted disease.9-Infection with ureaplasma.

Page 15: protein synthesis inhibitors 1.ppt
Page 16: protein synthesis inhibitors 1.ppt

Adverse effect

The incidence of S.E is very low

1- mild GI upset with nausea diarrhea & abdominal pain 2- general hypersensitivity [ rash, fever, eosinophilia ] 3- cholestatic hepatitis

C.I In patient with hepatic dysfunction, bec. The drug accumulated in the liver

Page 17: protein synthesis inhibitors 1.ppt

Ketolides Telithromycin: approved for limited clinical use.•It is active in vitro against streptococcus pyogenes, S pneumoniae, S aureus, H influenzae, Mycoplasma sp.,and H pylori.•Many macrolide-resistant strains are susceptible to ketolides.•Orally effective.•In the USA, telithromycin is now indicated only for treatment of community-acquired bacterial pneumonia.

Page 18: protein synthesis inhibitors 1.ppt